HNF4A and nasopharyngeal carcinoma: Vo levels delivered to lungs are boosted to sufficiently reduce macrophage levels in Npc1nmf164 mice, which significantly expands the potential of the TCF in treating all organ systems expected to affect the progression of NPC.